Literature DB >> 19353645

Further case of Rubinstein-Taybi syndrome due to a deletion in EP300.

Patricia Foley1, David Bunyan, John Stratton, Michelle Dillon, Sally Ann Lynch.   

Abstract

Rubinstein-Taybi syndrome (RSTS) is a heterogeneous disorder with approximately 45-55% of patients showing mutations in the CREB binding protein and a further 3% of patients having mutations in EP300. We report a male child with a deletion of exons 3-8 of the EP300 gene who has RSTS. He has a milder skeletal phenotype, a finding that has been described in other cases with EP300 mutations. The mother suffered from pre-eclampsia and HELLP syndrome in the pregnancy. She subsequently developed a mullerian tumor of her cervix 6 years after the birth of her son.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353645     DOI: 10.1002/ajmg.a.32771

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  Exome Sequencing Identification of EP300 Mutation in a Proband with Coloboma and Imperforate Anus: Possible Expansion of the Phenotypic Spectrum of Rubinstein-Taybi Syndrome.

Authors:  Koji Masuda; Kazuhiro Akiyama; Michiko Arakawa; Eriko Nishi; Noritaka Kitazawa; Tsukasa Higuchi; Yuki Katou; Katsuhiko Shirahige; Kosuke Izumi
Journal:  Mol Syndromol       Date:  2015-03-03

2.  High frequency of copy number imbalances in Rubinstein-Taybi patients negative to CREBBP mutational analysis.

Authors:  Cristina Gervasini; Federica Mottadelli; Roberto Ciccone; Paola Castronovo; Donatella Milani; Gioacchino Scarano; Maria Francesca Bedeschi; Serena Belli; Alba Pilotta; Angelo Selicorni; Orsetta Zuffardi; Lidia Larizza
Journal:  Eur J Hum Genet       Date:  2010-02-03       Impact factor: 4.246

Review 3.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

4.  Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.

Authors:  Anne Chun-Hui Tsai; Cherilyn J Dossett; Carol S Walton; Andrea E Cramer; Patti A Eng; Beata A Nowakowska; Amber N Pursley; Pawel Stankiewicz; Joanna Wiszniewska; Sau Wai Cheung
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

Review 5.  Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome.

Authors:  Silvia Spena; Cristina Gervasini; Donatella Milani
Journal:  J Pediatr Genet       Date:  2015-09-28

Review 6.  Wnt/catenin signaling in adult stem cell physiology and disease.

Authors:  Alexander Ring; Yong-Mi Kim; Michael Kahn
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

7.  Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.

Authors:  Daniela Rusconi; Gloria Negri; Patrizia Colapietro; Chiara Picinelli; Donatella Milani; Silvia Spena; Cinzia Magnani; Margherita Cirillo Silengo; Lorena Sorasio; Vaclava Curtisova; Maria Luigia Cavaliere; Paolo Prontera; Gabriela Stangoni; Giovanni Battista Ferrero; Elisa Biamino; Rita Fischetto; Maria Piccione; Paolo Gasparini; Leonardo Salviati; Angelo Selicorni; Palma Finelli; Lidia Larizza; Cristina Gervasini
Journal:  Hum Genet       Date:  2015-03-25       Impact factor: 4.132

Review 8.  Rubinstein-Taybi syndrome: clinical features, genetic basis, diagnosis, and management.

Authors:  Donatella Milani; Francesca Maria Paola Manzoni; Lidia Pezzani; Paola Ajmone; Cristina Gervasini; Francesca Menni; Susanna Esposito
Journal:  Ital J Pediatr       Date:  2015-01-20       Impact factor: 2.638

9.  Meta-Analysis of Placental Transcriptome Data Identifies a Novel Molecular Pathway Related to Preeclampsia.

Authors:  Miranda van Uitert; Perry D Moerland; Daniel A Enquobahrie; Hannele Laivuori; Joris A M van der Post; Carrie Ris-Stalpers; Gijs B Afink
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

10.  Altering cancer transcriptomes using epigenomic inhibitors.

Authors:  Malaina Gaddis; Diana Gerrard; Seth Frietze; Peggy J Farnham
Journal:  Epigenetics Chromatin       Date:  2015-02-24       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.